Diagnostic and Therapeutic Hindrance of Severe Non-bullous Impetigo Contagiosa in a Rural Nepalese Child: A Case Report
DOI:
https://doi.org/10.3126/njdvl.v24i1.82984Keywords:
MRSA, Impetigo, Doxycycline, DermatologyAbstract
Impetigo is a common, contagious superficial bacterial skin infection predominantly affecting children aged two to five years. Severe presentations are rare but can be diagnostically and therapeutically challenging, particularly in rural, resource-limited settings. We report a 7-year-old girl from rural Nepal with severe non-bullous impetigo contagiosa unresponsive to initial therapy with topical mupirocin and oral cephalexin. Due to the absence of culture and sensitivity facilities and the high regional prevalence of methicillin-resistant Staphylococcus aureus (MRSA), empirical oral doxycycline was initiated. Marked improvement occurred within 48 hours, with complete resolution by day 7. This case underscores the importance of flexible, evidence-based empirical therapy for suspected MRSA in pediatric patients when diagnostic resources are unavailable, and highlights the short-term safety and efficacy of doxycycline in children.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Nepal Journal of Dermatology, Venereology & Leprology

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright on any research article is transferred in full to Nepal Journal of Dermatology, Venereology & Leprology upon publication. The copyright transfer includes the right to reproduce and distribute the article in any form of reproduction (printing, electronic media or any other form).